Home  >  News
Research + Font Resize -

Topas Therapeutics exclusive partner for CRC focused on liver inflammation at University Medical Center, Hamburg-Eppendorf

Hamburg
Tuesday, January 30, 2018, 17:00 Hrs  [IST]

Topas Therapeutics GmbH (Topas), a Hamburg, Germany-based private platform company, announced that it will serve as the exclusive translational partner for the recently extended Collaborative Research Center (CRC) 841, "Liver inflammation: infection, immune regulation and consequences." CRC 841 has 25 sub-projects investigating the causes and mechanisms of inflammatory liver diseases, laying the groundwork for new therapeutic approaches.

Collaborative Research Centers (CRCs) are funded by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG). CRC 841 at the UKE has been funded by the DFG since 2010 and will now receive nearly EUR 15 million for the third and final projects phase.

Professor Ansgar W. Lohse, Chief of the I. Medical Clinic and Polyclinic for Internal Medicine at the UKE and CRC spokesperson, said: "From the very beginning, the translation of research into potential clinical applications has been a focus of CRC 841, and we now expect a nanomedicine for the treatment of autoimmune diseases originally developed at CRC 841 to enter human clinical testing in 2019. The collaboration with Topas has been a great success and we look forward to continuing to work together."

Topas plans to translate the eight years of research of CRC 841 into clinical development. In addition, Topas will cooperate closely with various members of the CRC to explore additional applications of Topas' immune tolerance approach in various indications and to integrate these into Topas' project portfolio, where appropriate.

Topas Therapeutics GmbH is a private Hamburg, Germany-based biotechnology company focused on developing products to address areas of major unmet need, including autoimmune diseases, allergies and anti-drug antibodies.

 

*POST YOUR COMMENT
Comments
* Name :     
* Email :    
  Website :  
   
     
 
IPE_2018_Banner_150X60
InnoPack-Pharma_150x60_2018
GPRS_150x60_2018
cphikorea_150x60_saffron media
Chemspec_India-2018
IPX_Logo_2018_150x60_web
CPHI18_banner_150x6
CPhI_China_150x60-2018
PharmaTech_Expo_2018
VF118_Banner_150x60_E_D2
duphat_150x60
IPJPI18_150x60en_2018
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |